Learning Objectives
After watching this webinar, participants will be able to:
Needs assessment and expected educational outcome
To learn how to identify patients with worsening HF at an early stage, how to optimise medical therapy, and how to use biomarkers/imaging to identify signs of worsening.
This programme is supported by Bayer AG in the form of an unrestricted financial support. The scientific programme has not been influenced in any way by its sponsor.
Main Topic
Session information
This webinar is designed for all healthcare professionals having an interest in heart failure, and those wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).
Watch the other webinar of the series:
Clinical challenges of optimising GDMT in WHF on 31/10/2023